BIOCRYST IRELAND LIMITED

Biocryst Ireland Limited is a specialised biotech company that leverages more than three decades of global experience in drug discovery, development and commercialisation. Guided by a passion for delivering extraordinary medicines, the company focuses on creating first-in-class or best-in-class oral small-molecule and protein therapeutics for patients with rare and challenging disease categories, notably hereditary angioedema (HAE) and other rare disorders.

Using a novel, structure-guided approach that blends traditional biology, medicinal chemistry and advanced technologies, Biocryst develops novel therapeutics that aim to improve everyday life for patients and their families. The firm's transparent, supportive culture turns challenges into resilience, empowering its people to exceed expectations while maintaining a patient-centred ethos. By listening to patients and collaborating with advocacy organisations, Biocryst strives to bring the right treatments into the hands of those who need them most, moving the needle - and even mountains - in rare-disease care.